The United States Patent and Trademark Office (USPTO) has issued patent US12582750B2, titled "Method for producing transplantable oral mucosa tissue," to MUKOCELL GMBH. The patent details a method for selecting and producing transplantable oral mucosa tissue using specific markers, intended for use as pharmaceutical compositions, medicaments, or transplant materials. This includes applications in urethral reconstruction and cornea implantation, focusing on the production of autologous oral mucosa grafts.

This patent grant represents a new intellectual property right for MUKOCELL GMBH. While not a regulatory rule imposing obligations on other entities, it signifies a novel development in the field of regenerative medicine and tissue engineering. Companies operating in the biotechnology, pharmaceutical, and medical device sectors, particularly those involved in tissue grafting or reconstructive surgery, should be aware of this patent's scope as it may impact their research, development, and commercialization activities in related areas.